144 ·Filed Jun 26, 2026

PSNL

Personalis, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001950047-26-006542
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine pre-planned sale under a 10b5-1 trading plan by a director/officer. The amount is modest relative to market cap. No material signal for the stock. Monitor for any acceleration in selling or deviation from the plan.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
PSNL ▲ +18.98% at T+60d
NEUTRAL call ✓ call won +18.98% · α vs SPY +14.60% · entry $13.75 → $16.36
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
-2.55%
call -2.55% · α -3.32%
$13.40
settled 3mo ago
T+5d
+4.29%
call +4.29% · α +2.90%
$14.34
settled 3mo ago
T+20d
-14.33%
call -14.33% · α -14.05%
$11.78
settled 2mo ago
T+60d
+18.98%
call +18.98% · α +14.60%
$16.36
settled 10d ago

Price Chart

Loading chart...

Executive Summary

Director and Officer Christopher Hall filed a Form 144 indicating intent to sell 100,000 shares of Personalis common stock, valued at approximately $1.26 million, on June 26, 2026. The sale is part of an existing 10b5-1 trading plan, with prior sales of ~$1.1M in late May, making this a routine pre-planned transaction.

Key Facts

  • Insider Christopher Hall (Director & Officer) intends to sell 100,000 shares of PSNL common stock.
  • Estimated market value of proposed sale: $1,259,000.
  • Sale is scheduled for June 26, 2026, on NASDAQ.
  • Shares are acquired through exercise of stock options.
  • Sale is part of a pre-existing 10b5-1 trading plan; prior sales under the plan occurred on May 28-29, 2026 (total ~100,000 shares for ~$1.1M).
  • Proposed sale represents ~0.09% of PSNL's $1.4B market cap.

Financial Impact

Proposed sale of $1.26M in PSNL common stock, representing ~0.09% of market cap.

dilution

Risk Factors

  • Potential for further insider selling if the 10b5-1 plan is expanded or if additional plans are adopted.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006542
Document: 0001950047-26-006542-index.html0001950047-26-006542
Document: 0001950047-26-006542.txt0001950047-26-006542
14 reports for PSNL
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+20▲ +14.48%Aug 9, 2026
Filters
Rows
Reports for PSNL — sortable, filterable
TypeNow
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$14.50 $16.60▲ +14.48%▲ +15.40%$16.28 (+12.28%)
Jul 20, 2026
10w ago
425
BULLISH ★ 7/10
$13.44 $13.91▲ +3.50%▲ +0.94%$16.28 (+21.13%)
Jul 20, 2026
10w ago
8-K
NEUTRAL ★ 6/10
$13.44 $13.91▲ +3.50%▲ +0.94%$16.28 (+21.13%)
Jul 20, 2026
10w ago
425
BULLISH ★ 7/10
$13.34 $13.89▲ +4.12%▲ +0.00%$16.28 (+22.04%)
Jul 20, 2026
10w ago
8-K
BULLISH ★ 7/10
$13.34 $13.89▲ +4.12%▲ +0.00%$16.28 (+22.04%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 4/10
$15.58 $14.42▼ −7.45%▼ −11.06%$16.28 (+4.49%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$13.40 $11.98▼ −10.60%▼ −9.57%$16.28 (+21.49%)
Jun 26, 2026
14w ago
144
NEUTRAL ★ 3/10
$13.75 $11.78▼ −14.33%▼ −14.05%$16.28 (+18.40%)
Jun 26, 2026
14w ago
144
NEUTRAL ★ 2/10
$13.75 $11.78▼ −14.33%▼ −14.05%$16.28 (+18.40%)
Jun 6, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$10.04 $14.34▲ +42.83%▲ +41.20%$16.28 (+62.15%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (64h 18m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access